Skip to main content
Clinical Trials/NCT02061787
NCT02061787
Recruiting
Not Applicable

the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension

Chinese Pulmonary Vascular Disease Research Group1 site in 1 country4,000 target enrollmentSeptember 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary Hypertension
Sponsor
Chinese Pulmonary Vascular Disease Research Group
Enrollment
4000
Locations
1
Primary Endpoint
achievement of low risk
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment

Detailed Description

patients diagnosed with pulmonary hypertension, including pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension, will be evaluated by cardio pulmonary exercise test before and after medical or balloon pulmonary angioplasty treatment

Registry
clinicaltrials.gov
Start Date
September 2010
End Date
September 8, 2030
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Chinese Pulmonary Vascular Disease Research Group
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • pulmonary arterial hypertension;( WHO1)
  • chronic thromboembolic pulmonary hypertension;
  • pulmonary arterial hypertension due to other cause;

Exclusion Criteria

  • massive hemoptysis;
  • unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders;
  • recent recurrent syncope;
  • pulmonary hypertension due to hypoxia;
  • pulmonary hypertension due to left heart diseases.

Outcomes

Primary Outcomes

achievement of low risk

Time Frame: 5 years

patients with chronic thromboembolic pulmonary hypertension achievement of low risk after balloon pulmonary angioplasty

mean pulmonary arterial pressure after treatment

Time Frame: 5 years

the mean pulmonary arterial pressure of patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty treatment

all cause mortality

Time Frame: 5 years

all cause mortality

Secondary Outcomes

  • deterioration of WHO function(5 years)

Study Sites (1)

Loading locations...

Similar Trials